Akashi Therapeutics, Inc.

Akashi Therapeutics, Inc. company information, Employees & Contact Information

Akashi Therapeutics is a clinical stage biotechnology company developing a portfolio of products for Duchenne muscular dystrophy and other rare diseases. The lead clinical asset is HT-100, and drug candidate with potent anti-inflammatory and anti-fibrotic properties that also promotes healthy muscle regeneration. The company's second clinical candidate is DT-200, a Selective Androgen Receptor Modulator (SARM), targeted to build muscle mass and strength. Akashi is a combination of Halo Therapeutics and Dart Therapeutics, two companies founded as a collaboration between patient advocacy organizations and biotechnology industry veterans. Akashi is lead by a team of experienced drug developers.

Company Details

Employees
3
Founded
-
Address
Cambridge, Ma
Phone
617-431-7250
Email
IN****@****TRX.COM
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Chanhassen.
HQ
Cambridge, MA
Looking for a particular Akashi Therapeutics, Inc. employee's phone or email?

Akashi Therapeutics, Inc. Questions

Top Akashi Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant